NEW MJ NEWS

Tilray Brands, Inc. to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on July 26, 2023

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2023 on July 26, 2023.

Live Audio Webcast

Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray’s website at www.Tilray.com. A replay will be available and archived on the Company’s website.

Retail Investor Q&A

Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until July 25, 2023. To submit questions ahead of the webcast, please visit the Say Technologies platform at https://app.saytechnologies.com/tilray-brands-2023-q4.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @tilray on all social platforms.

For further information:
Media: Berrin Noorata, news@tilray.com
Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

1933 Industries Inc. (TGIF.CN) (TGIFF) Grants Stock Options and Cancels Extraordinary Meeting of Debentureholders

1933 Industries Grants Stock Options and Cancels Extraordinary Meeting of Debentureholders  …

INSYS Therapeutics (INSY) Presents New Clinical Data from Long-Term Safety Study of CBD

INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD…

$INSY Receives FDA Orphan Drug Designation

  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol…

$VPOR Gives Update on VGR Media, Inc. Acquisition

Vapor Group, Inc., VPOR, Provides Additional Information on the Use of Preferred…